Moberg Pharma AB (Formerly known as Moberg Derma) Divests Three Brands For $10.0 Million

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

Moberg Pharma (STO:MOB)

Moberg Pharma AB (OMX: MOB) announces that the company has entered into an agreement with Strides Pharma Inc. to divest the brands Jointflex, Fergon and Vanquish for a total consideration of $10 million plus the inventory value at closing.
MORE ON THIS TOPIC